Statement of Regulatory Intent definition

Statement of Regulatory Intent means a statement of the same name published by the Victorian Office of the Conservation Regulator, which provides a detailed explanation of the law in a specified area and guidance on how the regulator will exercise its powers;
Sample 1Sample 2Sample 3

Examples of Statement of Regulatory Intent in a sentence

  • This is what the T-corps are required to do under the National Competition Policy.The AER has advised that it has used the approach implied in the Rules and its own Statement of Regulatory Intent and this has resulted in the higher values for DRP than used historically.

  • The Statement of Regulatory Intent from this review was published in May 2009 and the AER has adopted an equity beta estimate of 0.8 in all gas and electricity network determinations since 27 Envestra Draft Decision, Appendix B, pp.

  • The Statement of Regulatory Intent does not have regard to the possibility of external factors and does not make any adjustments in the calculation of the efficiency gain or loss.

  • This Statement of Regulatory Intent provides for the AER to determine whether a negative carryover amount should be deferred or offset any future positive carryover amount.

  • Specifically, the QRC has stated that “if the QCA consider it appropriate to increase Aurizon Network’s maintenance allowance the QRC confirm that it supports that increase”.3 Regulatory processHaving initiated the UT5 process on 11 May 2016, the QCA released its Statement of Regulatory Intent (SORI) in July 2016.

  • Prior to the last process for setting the AER’s Statement of Regulatory Intent ( SoRI), the long- standing regulatory precedent was to set gamma equal to 0.5. In its SoRI in May 2009, the AER set gamma to 0.65.

  • In this case, however, the AER can undertake reviews more frequently than every five years.245 The output of the WACC review is referred to as the Statement of Regulatory Intent (SORI).246The MCE introduced another important difference in the Chapter 6 framework that is absent from Chapter 6A of the NER.

  • If CDSS has not provided the translation, the CWD must ensure that effective bilingual services are provided as discussed in ACL 08-65 (December 31, 2008) “Documentation of Interpretative Services;” MPP §22-001(l)(1) sets out the requirements for a NOA to be language compliant.

  • Over 2008-2009, the Australian Energy Regulator (AER) undertook a Review of WACC Parameter Estimates, culminating in a Statement of Regulatory Intent (SoRI) in May 2009.

  • SP AusNet’s positionUnder this section of the Consultation Paper, the Commission proposes to use gamma value as per the AER’s most recent Statement of Regulatory Intent when establishing the benchmark for corporate Tax as per Section 4.1(f)(v).

Related to Statement of Regulatory Intent

  • MAA means an application for the authorization to market any Product in any country or group of countries outside the United States, as defined in the applicable laws and regulations and filed with the Governmental Authority of a given country or group of countries.

  • Disclosure Statement Approval Order means the Final Order approving, among other things, the adequacy of the Disclosure Statement pursuant to section 1125 of the Bankruptcy Code.

  • Regulatory Filing means any approvals, licenses, registrations, submissions and authorizations, and applications therefor, including IND, NDA, BLA, drug dossier or drug master file filed, or Marketing Approval obtained, with respect to an Option Product, Licensed Product or Companion Diagnostic, as applicable, in the Field, including all amendments, supplements, annual reports and the like thereof or therefor filed with or otherwise provided to the applicable Regulatory Authority.

  • UCC Filing Authorization Letter means a letter duly executed by each Loan Party authorizing the Agent to file appropriate financing statements on Form UCC-1 without the signature of such Loan Party in such office or offices as may be necessary or, in the opinion of the Agent, desirable to perfect the security interests purported to be created by each Security Agreement, each Pledge Agreement and each Mortgage.

  • Fee and Expense Application means the motion to be filed by Class Counsel, in which they will seek approval of an award of attorneys’ fees, costs, and expenses, as well as an Incentive Award for the Class Representative.

  • Regulatory Approval Application means an application to seek regular or expedited Regulatory Approval of the Licensed Product for sale or marketing in any country(ies) or Region(s) in the Territory, as defined in the applicable Laws and filed with the Regulatory Authority of such country(ies) or Region(s).

  • Approval Application means a BLA, NDA or similar application or submission for a Product filed with a Regulatory Authority in a country or group of countries to obtain marketing approval for a biological or pharmaceutical product in that country or group of countries.

  • Tax Regulatory Agreement means the Tax Regulatory Agreement dated as of the date hereof by and among the Company, the Issuer and the Trustee.

  • Drug Master File or “DMF” is described in 21 C.F.R. Part 314.420. A DMF is a submission to the FDA that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs.

  • Foreign Financial Regulatory Authority shall have the meaning given by Section 2(a)(50) of the 0000 Xxx.

  • Disclosure Statement Order means the order of the Bankruptcy Court approving the Disclosure Statement.

  • MI Reporting Template means the form of report set out in the Annex to Framework Schedule 8 (Management Information) setting out the information the Supplier is required to supply to the Authority;

  • MI Report means a report containing Management Information submitted to the Authority in accordance with Framework Schedule 8 (Management Information);

  • CCC means Customer Care Centre

  • Licensed Independent Practitioner means any individual permitted by law and by the Medical Staff and Board to provide care and services without direction or supervision, within the scope of the individual’s license and consistent with individually granted clinical privileges.

  • Biologics License Application or “BLA” means an application requesting permission from the FDA to introduce, or deliver for introduction, a biological product into interstate commerce, or any similar application or submission for marketing authorization of a product filed with a Regulatory Authority to obtain Regulatory Approval for such product in a country or group of countries.

  • Master File has the meaning set forth in the CAISO Tariff.

  • closing agreement as described in Section 7121 of the Code (or any corresponding or similar provision of state, local or foreign income Tax law) executed on or prior to the Closing Date; (iii) installment sale or open transaction disposition made on or prior to the Closing Date; or (iv) prepaid amount received on or prior to the Closing Date;

  • StarCompliance Code of Ethics application means the web-based application used to electronically pre-clear personal securities transactions and file many of the reports required herein. The application can be accessed via the AB network at: https://alliance-ng.starcompliance.com/.

  • Listing Statement means the listing statement of the Acquiror in accordance with requirements of the CSE in respect of the Transaction;

  • CMC means Comprehensive maintenance Contract (labour, spare and preventive maintenance)

  • Drug Approval Application means, with respect to a Licensed Product in the Territory, an application for Regulatory Approval for such product in a country in the Territory. For purposes of clarity, Drug Approval Application shall include, without limitation, (a) an NDA or BLA (for U.S.) or MAA (for Europe); (b) a counterpart of an NDA, BLA or MAA in any country or region in the Territory; and (c) all supplements (including supplemental applications such as sNDAs) and amendments to the foregoing.

  • Marketing Approval Application or “MAA” means a New Drug Application (or its equivalent), as defined in the U.S. Food, Drug and Cosmetic Act and the regulations promulgated thereunder, or any corresponding or similar application, registration or certification in any country.